Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,027 public trials 268 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Completed

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies

NCT01635712

Conditions
Cancer, Hematologic Diseases, Hematologic Neoplasms, +3 more
Locations
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Georgia Regents University Cancer Center Augusta, Georgia, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Wake Forest Baptist Health Winston-Salem, North Carolina, United States
View Trial Details
Completed

Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies

NCT00446342

Conditions
B-Lymphoid Malignancies, Blood Protein Disorders, Cardiovascular Diseases, +29 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Winship Cancer Institute at Emory University Atlanta, Georgia, United States
  • Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
View Trial Details
Completed

Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib

NCT01831726

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +47 more
Locations
  • Alabama Oncology Birmingham, Alabama, United States
  • Highlands Oncology Group SC Fayetteville, Arkansas, United States
  • PCR Oncology Pismo Beach, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
View all 49 locations
View Trial Details
Completed

AMG 319 Lymphoid Malignancy FIH

NCT01300026

Conditions
Cancer, Chronic Disease, Chronic Lymphocytic Leukemia, +33 more
Locations
  • Research Site Hackensack, New Jersey, United States
  • Research Site Durham, North Carolina, United States
  • Research Site Salt Lake City, Utah, United States
View Trial Details
Completed

A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies

NCT00402714

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations
  • Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States
  • Tufts-New England Medical Center Boston, Massachusetts, United States
  • Methodist Hospital - Texas Transplant Institute San Antonio, Texas, United States
View Trial Details

Related conditions